TB-500: Thymosin Beta-4

• May support recovery and comfort after strain or activity
• May support flexibility and joint mobility
• May help reduce soreness and support recovery time

‍

• Cycle length: Commonly used for 4 to 6 weeks, depending on recovery goals
• Dosing: Administered by subcutaneous injection under provider supervision
• Stacking: Frequently paired with BPC-157 for enhanced tissue healing, or with MOTS-c for energy and recovery support

‍

• Athletes or active adults recovering from injuries or repetitive strain
• People managing chronic joint or tendon discomfort
• Patients looking to accelerate post-surgical healing
• Individuals seeking to improve overall recovery and mobility

‍

• Some people report improved mobility and comfort within weeks
• Effects often build with consistent cycles
• Works well when paired with proper rehabilitation, nutrition, and exercise
• Individual outcomes may vary depending on health status and treatment plan

‍

These statements have not been evaluated by the Food and Drug Administration (FDA). Compounded peptide therapies are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease. They are prepared by appropriately licensed U.S. compounding pharmacies pursuant to a valid, patient-specific prescription when determined medically appropriate by the treating physician. Treatment is individualized following a physician evaluation, and individual results vary.